Status:
NOT_YET_RECRUITING
TEG Use in Children Undergoing Procedures With High Anticipated Blood Loss
Lead Sponsor:
Boston Children's Hospital
Conditions:
Surgical Blood Loss
Surgical Hemorrhage
Eligibility:
All Genders
Up to 20 years
Phase:
NA
Brief Summary
The research team proposes a prospective, observational study to better understand how TEG can be useful in guiding clinical practice in the Main OR for subject's undergoing high transfusion risk surg...
Detailed Description
Intraoperatively, transfusion of blood products is frequently required to restore oxygen carrying capacity, perfusion and improve coagulation. Both under and over transfusion pose significant risks, p...
Eligibility Criteria
Inclusion
- Pediatric patients undergoing non-cardiac surgery at BCH with a high likelihood of blood transfusion. Specifically these are defined as a surgery with greater than 25% likelihood of transfusion of any non-albumin blood product.
- Eligible surgeries include:
- spinal surgery
- laparotomy
- liver transplant
- craniofacial surgery
- esophageal atresia
- craniotomy/hemispherectomy
- major abdominal surgery
- major hip surgery
- major plastic surgery
Exclusion
- Patients undergoing cardiac surgery or ECMO cannulation, as these surgeries are generally considered outside the scope of general pediatric surgery.
- Patients presenting for emergent surgery
- Patients undergoing surgeries off hours (between 8pm and 8 am), when TEG analysis is unobtainable
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05379530
Start Date
January 1 2025
End Date
December 1 2025
Last Update
August 20 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.